<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">

<channel>
	<title>BlogNetNews.com » Bio Tech</title>
	<link>http://www.blognetnews.com/biotech/</link>
	<description>BlogNetNews.com » Bio Tech</description>
	<generator>BlogNetNews.com</generator>
	<language>en</language>
	<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.feedburner.com/biotechBNN" type="application/rss+xml" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com" /><item>
		<title>Bio Job Blog: Signs of an Economic Recovery?  Spending on Direct-to-Consumer Advertising is on the Rise Again</title>
		<link>http://www.blognetnews.com/biotech/go.php?http://feeds.lexblog.com/~r/BioJobBlog/~3/nnE3ERgXABI/</link>
		<pubDate>Tue, 08 Dec 2009 17:31:50 -0500</pubDate>
		<guid>http://feeds.lexblog.com/~r/BioJobBlog/~3/nnE3ERgXABI/</guid>
		<description>&lt;img alt="" src="http://www.biojobblog.com/uploads/image/economic_recovery.gif" /&gt;&lt;p&gt;A &lt;a href="http://www.pharmalot.com/2009/12/dtc-ad-spending-is-on-the-rise-again/"&gt;post on the Pharmalot blog&lt;/a&gt; today reports that spending on direct-to-consumer pharmaceutical advertising came bounding back in the third quarter &amp;mdash;rising 15 percent to $1.16 billion, according to &lt;a href="http://www.dtcperspectives.com/article/DTC-INSIGHTS-Alert+dots+-+em+Reported+em+-DTC-Ad-Spending-Rebounds-in-July%7ESept.-Period/207.html"&gt;DTC Perspectives&lt;/a&gt; (which cited data from TNS Media Intelligence).&lt;/p&gt;
&lt;p&gt;The increased spending marks the first quarterly gain &lt;a href="http://www.blognetnews.com/biotech/go.php?http://feeds.lexblog.com/~r/BioJobBlog/~3/nnE3ERgXABI/" class="postLink" target="_blank"&gt;[...]&lt;/a&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/XblHBBNNl8pEDJ5-osbuu3qUI74/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/XblHBBNNl8pEDJ5-osbuu3qUI74/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/XblHBBNNl8pEDJ5-osbuu3qUI74/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/XblHBBNNl8pEDJ5-osbuu3qUI74/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;</description>
</item>

<item>
		<title>BioHealth Investor - Biotech and Medical Business Blog: Dendreon Files To Raise Capital (DNDN)</title>
		<link>http://www.blognetnews.com/biotech/go.php?http://www.biohealthinvestor.com/2009/12/dendreon-files-to-raise-capital-dndn.html</link>
		<pubDate>Tue, 08 Dec 2009 16:06:25 -0500</pubDate>
		<guid>http://www.biohealthinvestor.com/2009/12/dendreon-files-to-raise-capital-dndn.html</guid>
		<description>&lt;p&gt;Dendreon Corp. (NASDAQ: DNDN) has just filed an automatic shelf registration statement with the SEC.  This will allow the company to raise capital, although no terms nor dollar amounts were listed initially (see below).  As with most initial shelf registration of this sort, no underwriters were named as well (see &lt;a href="http://www.blognetnews.com/biotech/go.php?http://www.biohealthinvestor.com/2009/12/dendreon-files-to-raise-capital-dndn.html" class="postLink" target="_blank"&gt;[...]&lt;/a&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/awYP00_tToqxkdGG8pqWj0j64WQ/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/awYP00_tToqxkdGG8pqWj0j64WQ/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/awYP00_tToqxkdGG8pqWj0j64WQ/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/awYP00_tToqxkdGG8pqWj0j64WQ/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;</description>
</item>

<item>
		<title>Bio Job Blog: From the Are You Kidding Me Files: Pharm Giant Sales Force Goes Green With High Fashion Handbags</title>
		<link>http://www.blognetnews.com/biotech/go.php?http://feeds.lexblog.com/~r/BioJobBlog/~3/M7qVrryeTN8/</link>
		<pubDate>Tue, 08 Dec 2009 15:39:17 -0500</pubDate>
		<guid>http://feeds.lexblog.com/~r/BioJobBlog/~3/M7qVrryeTN8/</guid>
		<description>&lt;p&gt;As a blogger I get on average 2-3 press releases per day from publicists who want me to pick up their releases and publish them on BioJobBlog.&amp;nbsp;I usually pass. But, the one that I received from a publicist who represents eco-friendly and politically-correct Red Handed Bags was too good not &lt;a href="http://www.blognetnews.com/biotech/go.php?http://feeds.lexblog.com/~r/BioJobBlog/~3/M7qVrryeTN8/" class="postLink" target="_blank"&gt;[...]&lt;/a&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/sOLa9-vaEb6euM0OyR8scGTNYnU/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/sOLa9-vaEb6euM0OyR8scGTNYnU/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/sOLa9-vaEb6euM0OyR8scGTNYnU/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/sOLa9-vaEb6euM0OyR8scGTNYnU/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;</description>
</item>

<item>
		<title>Pharma Marketing Blog: Premature Social Media Promotion (PSMP): A New Pharma Syndrome</title>
		<link>http://www.blognetnews.com/biotech/go.php?http://pharmamkting.blogspot.com/2009/12/premature-social-media-promotion-psmp.html</link>
		<pubDate>Tue, 08 Dec 2009 13:03:00 -0500</pubDate>
		<guid>http://pharmamkting.blogspot.com/2009/12/premature-social-media-promotion-psmp.html</guid>
		<description>I've heard of pharmaceutical company blogs that were launched to promote a drug already on the market (ie, alliconnect), but I haven't seen a blog that was launched to promote a drug that isn't yet approved for marketing - until now!&lt;br /&gt;&lt;br /&gt;According to Jonathan D. Rockoff at WSJ Health' &lt;a href="http://www.blognetnews.com/biotech/go.php?http://pharmamkting.blogspot.com/2009/12/premature-social-media-promotion-psmp.html" class="postLink" target="_blank"&gt;[...]&lt;/a&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/dDpJCRtt_lFu2ZMhZhaPgGyUpxE/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/dDpJCRtt_lFu2ZMhZhaPgGyUpxE/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/dDpJCRtt_lFu2ZMhZhaPgGyUpxE/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/dDpJCRtt_lFu2ZMhZhaPgGyUpxE/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;</description>
</item>

<item>
		<title>BioHealth Investor - Biotech and Medical Business Blog: PharmAthene (PIP) Shares Crushed</title>
		<link>http://www.blognetnews.com/biotech/go.php?http://www.biohealthinvestor.com/2009/12/pharmathene-pip-shares-crushed.html</link>
		<pubDate>Tue, 08 Dec 2009 09:41:26 -0500</pubDate>
		<guid>http://www.biohealthinvestor.com/2009/12/pharmathene-pip-shares-crushed.html</guid>
		<description>&lt;p&gt;PharmAthene (AMEX:PIP) shares were crushed down 50% to $1.62. The stock has a 52-week low of $1.12 and a high of $4.31. PIP&amp;#8217;s market cap is down to $46 million.&lt;/p&gt;
&lt;p&gt;that the Department of Health and Human Services Biomedical Research and Development Authority (BARDA) has canceled its request for proposal (RFP) for &lt;a href="http://www.blognetnews.com/biotech/go.php?http://www.biohealthinvestor.com/2009/12/pharmathene-pip-shares-crushed.html" class="postLink" target="_blank"&gt;[...]&lt;/a&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/r_9wHc0yCTumrEolT7ncoVkDrW4/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/r_9wHc0yCTumrEolT7ncoVkDrW4/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/r_9wHc0yCTumrEolT7ncoVkDrW4/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/r_9wHc0yCTumrEolT7ncoVkDrW4/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;</description>
</item>

<item>
		<title>Pharma Marketing Blog: Transcripts of FDA's November 2009 Public Hearing on Social Media Available</title>
		<link>http://www.blognetnews.com/biotech/go.php?http://pharmamkting.blogspot.com/2009/12/transcripts-of-fdas-november-2009.html</link>
		<pubDate>Tue, 08 Dec 2009 08:35:00 -0500</pubDate>
		<guid>http://pharmamkting.blogspot.com/2009/12/transcripts-of-fdas-november-2009.html</guid>
		<description>&lt;img src='https://blogger.googleusercontent.com/tracker/8550428-3016716475732540042?l=pharmamkting.blogspot.com' alt='' /&gt;You can find the transcripts here:&lt;br /&gt;&lt;a href="http://bit.ly/7xs7YS"&gt;Day 1 (November 12, 2009)&lt;/a&gt;: PDF File, 507 pages&lt;a href="http://bit.ly/55FLp6"&gt;Day 2 (November 13, 2009)&lt;/a&gt;: PDF File, 517 pages&amp;nbsp;Enjoy! &lt;a href="http://www.blognetnews.com/biotech/go.php?http://pharmamkting.blogspot.com/2009/12/transcripts-of-fdas-november-2009.html" class="postLink" target="_blank"&gt;[...]&lt;/a&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/3BTopE72SZN6l7TJLtGB-a7vNPQ/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/3BTopE72SZN6l7TJLtGB-a7vNPQ/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/3BTopE72SZN6l7TJLtGB-a7vNPQ/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/3BTopE72SZN6l7TJLtGB-a7vNPQ/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;</description>
</item>


</channel>
</rss>
